Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022)
Abeona Therapeutics (ABEO) recorded quarterly Interest Expense - Others of $200000.0 in Q1 2022, down 84.93% quarter-over-quarter from $1.3 million in Q3 2020.
Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022) Analysis & Trends
Abeona Therapeutics' Interest Expense - Others history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2022.
- In Q1 2022, Interest Expense - Others changed N/A year-over-year to $200000.0; the TTM figure through Mar 2022 stood at $1.5 million (changed N/A YoY), while the FY2021 annual figure was $67000.0, down 98.37% from the prior year.
- Interest Expense - Others was $200000.0 for Q1 2022 at Abeona Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Interest Expense - Others ranged from a high of $1.3 million in Q3 2020 to a low of $2000.0 in Q4 2018.
- Historically, Interest Expense - Others has averaged $383000.0 across 3 years, with a median of $101500.0 in 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 200,000.00 |
| Sep 30, 2020 | 1.33 Mn |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |